Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Basma M Ibrahim, Michael D Tsifansky, Yan Yang & Yoon Yeo. (2011) Challenges and advances in the development of inhalable drug formulations for cystic fibrosis lung disease. Expert Opinion on Drug Delivery 8:4, pages 451-466.
Read now
Read now
Malgorzata Smola, Thierry Vandamme & Adam Sokolowski. (2008) Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases. International Journal of Nanomedicine 3:1, pages 1-19.
Read now
Read now
Pang N. Shek, Zacharias E. Suntres & James I. Brooks. (1994) Liposomes in Pulmonary Applications: Physicochemical Considerations, Pulmonary Distribution and Antioxidant Delivery. Journal of Drug Targeting 2:5, pages 431-442.
Read now
Read now
. (1993) Literature Alerts. Journal of Microencapsulation 10:4, pages 509-528.
Read now
Read now
Articles from other publishers (8)
S.K. Katiyar, S.N. Gaur, R.N. Solanki, Nikhil Sarangdhar, J.C. Suri, Raj Kumar, G.C. Khilnani, Dhruva Chaudhary, Rupak Singla, Parvaiz A. Koul, Ashok A. Mahashur, A.G. Ghoshal, D. Behera, D.J. Christopher, Deepak Talwar, Dhiman Ganguly, H. Paramesh, K.B. Gupta, Mohan Kumar T, P.D. Motiani, P.S. Shankar, Rajesh Chawla, Randeep Guleria, S.K. Jindal, S.K. Luhadia, V.K. Arora, V.K. Vijayan, Abhishek Faye, Aditya Jindal, Amit K. Murar, Anand Jaiswal, Arunachalam M, A.K. Janmeja, Brijesh Prajapat, C. Ravindran, Debajyoti Bhattacharyya, George D'Souza, Inderpaul Singh Sehgal, J.K. Samaria, Jogesh Sarma, Lalit Singh, M.K. Sen, Mahendra K. Bainara, Mansi Gupta, Nilkanth T. Awad, Narayan Mishra, Naveed N. Shah, Neetu Jain, Prasanta R. Mohapatra, Parul Mrigpuri, Pawan Tiwari, R. Narasimhan, R. Vijai Kumar, Rajendra Prasad, Rajesh Swarnakar, Rakesh K. Chawla, Rohit Kumar, S. Chakrabarti, Sandeep Katiyar, Saurabh Mittal, Sonam Spalgais, Subhadeep Saha, Surya Kant, V.K. Singh, Vijay Hadda, Vikas Kumar, Virendra Singh, Vishal Chopra & Visweswaran B. (2022) Indian Guidelines on Nebulization Therapy. Indian Journal of Tuberculosis 69, pages S1-S191.
Crossref
Crossref
Eric Wenzler, Dustin R. Fraidenburg, Tonya Scardina & Larry H. Danziger. (2016) Inhaled Antibiotics for Gram-Negative Respiratory Infections. Clinical Microbiology Reviews 29:3, pages 581-632.
Crossref
Crossref
Abdelbary M.A. Elhissi, Sarah R. Dennison, Waqar Ahmed, Kevin M.G. Taylor & David A. Phoenix. 2014. Novel Antimicrobial Agents and Strategies. Novel Antimicrobial Agents and Strategies
387
406
.
Moayad Alhariri & Abdelwahab Omri. (2013) Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection. Antimicrobial Agents and Chemotherapy 57:1, pages 569-578.
Crossref
Crossref
Amy Pope-Harman & Mauro Ferrari. 2007. BioMEMS and Biomedical Nanotechnology. BioMEMS and Biomedical Nanotechnology
193
212
.
Jean-Francois Marier, Jean Lavigne & Murray P. Ducharme. (2002)
Pharmacokinetics and Efficacies of Liposomal and Conventional Formulations of Tobramycin after Intratracheal Administration in Rats with Pulmonary
Burkholderia cepacia
Infection
. Antimicrobial Agents and Chemotherapy 46:12, pages 3776-3781.
Crossref
Crossref
Annemarie van't Veen, Johan W. Mouton, Diederik Gommers & Burkhard Lachmann. (1996) Pulmonary surfactant as vehicle for intratracheally instilled tobramycin in mice infected with Klebsiella pneumoniae. British Journal of Pharmacology 119:6, pages 1145-1148.
Crossref
Crossref
A OmriC BeaulacM BouhajibS MontplaisirM SharkawiJ Lagacé. (1994) Pulmonary retention of free and liposome-encapsulated tobramycin after intratracheal administration in uninfected rats and rats infected with Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 38:5, pages 1090-1095.
Crossref
Crossref